Time to next pulmonary exacerbation · adolescents and adults with cystic fibrosis
Digital technology probably leads to higher time to next pulmonary exacerbation compared with usual care (moderate certainty).
1 finding from 1 review
Exacerbations (number of people experiencing ≥ 1 exacerbations) · adolescents and adults with cystic fibrosis
Digital technology showed no clear difference in number of pulmonary exacerbations: number of participants… compared with usual care (moderate certainty).
1 finding from 1 review
Quality of life: change from baseline in CFQ‐R · adolescents and adults with cystic fibrosis
Digital technology showed no clear difference in qoL: change from baseline in CFQ‐R score compared with usual care (moderate certainty).
1 finding from 1 review
FEV1 (% predicted): mean change from baseline · adolescents and adults with cystic fibrosis
1 finding from 1 review
IV antibiotics: number of days on IV antibiotics · adolescents and adults with cystic fibrosis
Digital technology showed no clear difference in IV antibiotics: number of days on IV antibiotics compared with usual care (low certainty).
1 finding from 1 review
New micro‐organisms: number of participants in whom new organisms are detected · adolescents and adults with cystic fibrosis
Digital technology probably leads to lower new micro‐organisms: number of participants in whom new organisms… compared with usual care (moderate certainty).
1 finding from 1 review
Adverse events: number of treatment related adverse events · adolescents and adults with cystic fibrosis
1 finding from 1 review
Adherence to inhaled therapies cMPR · children aged 5 to 16 years
Digital technology (TIM) may leads to higher adherence to the inhaled treatment: compared with standard treatment (TBM) (low certainty).
1 finding from 1 review
Treatment burden · children aged 5 to 16 years
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
QoL · children aged 5 to 16 years
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
FEV1 (% predicted): mean change from baseline · children aged 5 to 16 years
Digital technology (TIM) showed no clear difference in FEV1 (mean change from baseline, % predicted) compared with standard treatment (TBM) (low certainty).
1 finding from 1 review
Pulmonary exacerbations · children aged 5 to 16 years
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Pulmonary exacerbations · adults (aged 16 years and over) with CF
Digital technology (web‐based platform CFHealthHub) probably leads to lower number of pulmonary exacerbations compared with usual care (moderate certainty).
1 finding from 1 review
Adherence to the inhaled treatment: percentage adherence · adults (aged 16 years and over) with CF
Digital technology (web‐based platform CFHealthHub) probably leads to higher adherence to the inhaled treatment: percentage adherence compared with usual care (moderate certainty).
1 finding from 1 review
Treatment burden · adults (aged 16 years and over) with CF
Digital technology (web‐based platform CFHealthHub) probably leads to higher treatment burden: CFQ‐R treatment burden domain score (higher score… compared with usual care (moderate certainty).
1 finding from 1 review
QoL · adults (aged 16 years and over) with CF
Digital technology (web‐based platform CFHealthHub) showed no clear difference in qoL: CFQ‐R domain scores at end of study compared with usual care (moderate certainty).
1 finding from 1 review
FEV1 % predicted · adults (aged 16 years and over) with CF
Digital technology (web‐based platform CFHealthHub) showed no clear difference in FEV1: mean FEV1 % predicted at end of study compared with usual care (low certainty).
1 finding from 1 review
Usability of digital health technology (medium term) · adults with CF
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Usability of digital health technology (medium term) · adolescents and adults with cystic fibrosis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Usability of digital health technology (medium term) · children and adults with CF
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found